Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Current Opinion in Rheumatology|September 27, 2023
Updates on translational and clinical research in systemic sclerosisShervin Assassi
The Lancet. Rheumatology|January 31, 2024
Plasma protein correlates of skin severity in systemic sclerosisShervin Assassi
Arthritis & Rheumatology (Hoboken, N.J.)|November 6, 2014
Reply: To PMID 24782356Shervin Assassi
BMJ (Clinical Research Ed.)|January 30, 2016
Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancerShervin Assassi
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2023
Autoantibody and Cancer Connection in Systemic Sclerosis: Type and Overlap MatterShervin Assassi
BMJ (Clinical Research Ed.)|November 28, 2015
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?Chandra Mohan, Shervin Assassi
Cytokine|January 28, 2019
Type I interferon dysregulation in Systemic SclerosisBrian Skaug, Shervin Assassi
Frontiers in Immunology|September 19, 2013
The role of type 1 interferon in systemic sclerosisMinghua Wu, Shervin Assassi
Current Treatment Options in Rheumatology|June 13, 2022
Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?Minghua Wu, Shervin Assassi
Current Opinion in Rheumatology|August 23, 2019
Biomarkers in systemic sclerosisBrian Skaug, Shervin Assassi
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Current Opinion in Rheumatology|September 27, 2023
Updates on translational and clinical research in systemic sclerosisShervin Assassi
The Lancet. Rheumatology|January 31, 2024
Plasma protein correlates of skin severity in systemic sclerosisShervin Assassi
Arthritis & Rheumatology (Hoboken, N.J.)|November 6, 2014
Reply: To PMID 24782356Shervin Assassi
BMJ (Clinical Research Ed.)|January 30, 2016
Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancerShervin Assassi
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2023
Autoantibody and Cancer Connection in Systemic Sclerosis: Type and Overlap MatterShervin Assassi
BMJ (Clinical Research Ed.)|November 28, 2015
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?Chandra Mohan, Shervin Assassi
Cytokine|January 28, 2019
Type I interferon dysregulation in Systemic SclerosisBrian Skaug, Shervin Assassi
Frontiers in Immunology|September 19, 2013
The role of type 1 interferon in systemic sclerosisMinghua Wu, Shervin Assassi
Current Treatment Options in Rheumatology|June 13, 2022
Dysregulation of Type 1 Interferon Signaling in Systemic Sclerosis: a Promising Therapeutic Target?Minghua Wu, Shervin Assassi
Current Opinion in Rheumatology|August 23, 2019
Biomarkers in systemic sclerosisBrian Skaug, Shervin Assassi
Pageof 24